DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Walter E. Washington Convention Center

2015 年 06 月 14 日 2:30 下午 - 2015 年 06 月 18 日 6:45 下午

801 Mount Vernon Place, NW, , Washington, DC 20001-3614 , USA

DIA 2015 51st Annual Meeting: Develop. Innovate. Advance.

Full conference and one-day registrants will have access to presentation PDFs through Friday, December 18, 2015 <A href="http://www.diaglobal.org/Flagship-Meetings/DIA-Annual-Meeting/Meeting-Program/ePac-Presentations-Access.aspx">Review Presentations </A>

Predictive Subgroup Methodologies and Molecular Basket Designs

Session Chair(s)

Robert A. Beckman, MD

Robert A. Beckman, MD

Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics

Georgetown University Medical Center, United States

Optimal designs for predictive biomarkers and their associated subgroups are presented from both the public health and drug developers' perspectives. Novel basket designs grouping tumors based on molecular characteristics will be discussed.

This session has been developed by the DIA Adaptive Design Scientific Working Group.

Learning Objective : Describe risks of subgroup identification and optimal nonadaptive and adaptive designs; Explain possibilities of basket or bucket trials which group tumors based on similar molecular characteristics including new methodologies in this area.

Speaker(s)

Carl-Fredrik  Burman, PhD

Optimizing the Biomarker Subpopulation Strategy in Late Stage Clinical Development

Carl-Fredrik Burman, PhD

AstraZeneca R&D, Sweden

Assoc. Prof. in Biostatistics, Chalmers Univ of Tech; Senior Principal Scientist

Robert A. Beckman, MD

Design for a Confirmatory Histology Agnostic Molecular Basket Study

Robert A. Beckman, MD

Georgetown University Medical Center, United States

Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics

Rajeshwari  Sridhara, PhD

Predictive Biomarker Classifiers and Molecular Classifiers: A Perspective

Rajeshwari Sridhara, PhD

FDA, United States

Senior Biostatistician Consultant, Oncology Center of Excellence, FDA

注册方法

Registration override should work.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。